BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15011810)

  • 1. Does patient cost sharing matter? Its impact on recommended versus controversial cancer screening services.
    Liang SY; Phillips KA; Tye S; Haas JS; Sakowski J
    Am J Manag Care; 2004 Feb; 10(2 Pt 1):99-107. PubMed ID: 15011810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cost sharing on screening mammography in Medicare health plans.
    Trivedi AN; Rakowski W; Ayanian JZ
    N Engl J Med; 2008 Jan; 358(4):375-83. PubMed ID: 18216358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The direct and indirect effects of cost-sharing on the use of preventive services.
    Solanki G; Schauffler HH; Miller LS
    Health Serv Res; 2000 Feb; 34(6):1331-50. PubMed ID: 10654834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast, colon, and prostate screening in the adult population of Croatia: does rural origin matter?
    Polasek O; Kolcic I; Voncina L; Strnad M; Vuletic S; Kern J
    Rural Remote Health; 2007; 7(3):749. PubMed ID: 17900222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are gatekeeper requirements associated with cancer screening utilization?
    Phillips KA; Haas JS; Liang SY; Baker LC; Tye S; Kerlikowske K; Sakowski J; Spetz J
    Health Serv Res; 2004 Feb; 39(1):153-78. PubMed ID: 14965082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moving beyond the typologies of managed care: the example of health plan predictors of screening mammography.
    Tye S; Phillips KA; Liang SY; Haas JS
    Health Serv Res; 2004 Feb; 39(1):179-206. PubMed ID: 14965083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are women with functional limitations at high risk of underutilization of mammography screening?
    Ahmed NU; Smith GL; Haber G; Belcon MC
    Womens Health Issues; 2009; 19(1):79-87. PubMed ID: 19111790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cost sharing on screening mammography.
    Dhalla IA; Kiran T
    N Engl J Med; 2008 May; 358(22):2411; author reply 2411-2. PubMed ID: 18509131
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma.
    Dormuth CR; Glynn RJ; Neumann P; Maclure M; Brookhart AM; Schneeweiss S
    Clin Ther; 2006 Jun; 28(6):964-78; discussion 962-3. PubMed ID: 16860179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late-stage breast cancer among women with recent negative screening mammography: do clinical encounters offer opportunity for earlier detection?
    Mouchawar J; Taplin S; Ichikawa L; Barlow WE; Geiger AM; Weinmann S; Gilbert J; Manos MM; Ulcickas Yood M
    J Natl Cancer Inst Monogr; 2005; (35):39-46. PubMed ID: 16287884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health maintenance and screening in breast cancer survivors in the United States.
    Duffy CM; Clark MA; Allsworth JE
    Cancer Detect Prev; 2006; 30(1):52-7. PubMed ID: 16455209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Likelihood of additional work-up among women undergoing routine screening mammography: the impact of age, breast density, and hormone therapy use.
    Carney PA; Kasales CJ; Tosteson AN; Weiss JE; Goodrich ME; Poplack SP; Wells WS; Titus-Ernstoff L
    Prev Med; 2004 Jul; 39(1):48-55. PubMed ID: 15207985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What factors are associated with diagnostic follow-up after abnormal mammograms? Findings from a U.S. National Survey.
    Yabroff KR; Breen N; Vernon SW; Meissner HI; Freedman AN; Ballard-Barbash R
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):723-32. PubMed ID: 15159302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer screening in women aged 80 and older: results from a national survey.
    Schonberg MA; McCarthy EP; Davis RB; Phillips RS; Hamel MB
    J Am Geriatr Soc; 2004 Oct; 52(10):1688-95. PubMed ID: 15450046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Medicare Part D on access to and cost sharing for specialty biologic medications for beneficiaries with rheumatoid arthritis.
    Polinski JM; Mohr PE; Johnson L
    Arthritis Rheum; 2009 Jun; 61(6):745-54. PubMed ID: 19479704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of premium, copayments, and health status on the choice of health plans.
    Naessens JM; Khan M; Shah ND; Wagie A; Pautz RA; Campbell CR
    Med Care; 2008 Oct; 46(10):1033-40. PubMed ID: 18815524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast and cervical cancer screening among low-income women in Nebraska: findings from the Every Woman Matters program, 1993-2004.
    Feresu SA; Zhang W; Puumala SE; Ullrich F; Anderson JR
    J Health Care Poor Underserved; 2008 Aug; 19(3):797-813. PubMed ID: 18677071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of health insurance coverage in cancer screening utilization.
    Robinson JM; Shavers V
    J Health Care Poor Underserved; 2008 Aug; 19(3):842-56. PubMed ID: 18677074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary care practice and facility quality orientation: influence on breast and cervical cancer screening rates.
    Goldzweig CL; Parkerton PH; Washington DL; Lanto AB; Yano EM
    Am J Manag Care; 2004 Apr; 10(4):265-72. PubMed ID: 15124503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does health insurance coverage of office visits influence colorectal cancer testing?
    Varghese RK; Friedman C; Ahmed F; Franks AL; Manning M; Seeff LC
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):744-7. PubMed ID: 15767362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.